Cargando…

Deletion of NAD(P)H Oxidase 2 Prevents Angiotensin II-Induced Skeletal Muscle Atrophy

Skeletal muscle atrophy is induced by an imbalance between protein synthesis and degradation. Our previous studies reported that angiotensin II (AII) directly induced muscle atrophy in mice. This study investigated the role of NAD(P)H oxidase 2 (Nox2) activation by AII in the induction of skeletal m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadoguchi, Tomoyasu, Takada, Shingo, Yokota, Takashi, Furihata, Takaaki, Matsumoto, Junichi, Tsuda, Masaya, Mizushima, Wataru, Fukushima, Arata, Okita, Koichi, Kinugawa, Shintaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816890/ https://www.ncbi.nlm.nih.gov/pubmed/29487866 http://dx.doi.org/10.1155/2018/3194917

Ejemplares similares

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice
por: Furihata, Takaaki, et al.
Publicado: (2016)

Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure
por: Tsuda, Masaya, et al.
Publicado: (2018)

Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high‐fat diet‐induced diabetes
por: Takada, Shingo, et al.
Publicado: (2015)

Mitochondrial respiration of complex II is not lower than that of complex I in mouse skeletal muscle
por: Maekawa, Satoshi, et al.
Publicado: (2019)

Pioglitazone improves whole‐body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome
por: Yokota, Takashi, et al.
Publicado: (2017)

Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure
por: Furihata, Takaaki, et al.
Publicado: (2021)

Effect of multiple set on intramuscular metabolic stress during low-intensity resistance exercise with blood flow restriction
por: Suga, Tadashi, et al.
Publicado: (2012)

Clinical Impact and Associated Factors of Delayed Ambulation in Patients With Acute Heart Failure
por: Ishikawa, Koji, et al.
Publicado: (2019)

Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
por: Furihata, Takaaki, et al.
Publicado: (2021)

The AppCare-HF randomized clinical trial: a feasibility study of a novel self-care support mobile app for individuals with chronic heart failure
por: Yokota, Takashi, et al.
Publicado: (2023)

Systemic oxidative stress is associated with lower aerobic capacity and impaired skeletal muscle energy metabolism in heart failure patients
por: Yokota, Takashi, et al.
Publicado: (2021)

Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients
por: Shirakawa, Ryosuke, et al.
Publicado: (2019)

Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults
por: Shirakawa, Ryosuke, et al.
Publicado: (2023)

Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure
por: Takada, Shingo, et al.
Publicado: (2022)

Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction
por: Abe, Takahiro, et al.
Publicado: (2020)

Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis
por: Nakajima, Takayuki, et al.
Publicado: (2019)

Linoleic acid improves assembly of the CII subunit and CIII2/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure
por: Maekawa, Satoshi, et al.
Publicado: (2019)

Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases
por: Takada, Shingo, et al.
Publicado: (2022)

Possible Role of NADPH Oxidase 4 in Angiotensin II-Induced Muscle Wasting in Mice
por: Kadoguchi, Tomoyasu, et al.
Publicado: (2018)

Abnormalities of Skeletal Muscle, Adipocyte Tissue, and Lipid Metabolism in Heart Failure: Practical Therapeutic Targets
por: Takada, Shingo, et al.
Publicado: (2020)

Ergogenic effects of caffeine are mediated by myokines
por: Takada, Shingo, et al.
Publicado: (2022)

Impact of Inadequate Calorie Intake on Mortality and Hospitalization in Stable Patients with Chronic Heart Failure
por: Obata, Yoshikuni, et al.
Publicado: (2021)

Systemic Oxidative Stress Is Associated With Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients With Metabolic Syndrome
por: Yokota, Takashi, et al.
Publicado: (2013)

Progressive Mobilization Program for Patients With Acute Heart Failure Reduces Hospital Stay and Improves Clinical Outcome
por: Kakutani, Naoya, et al.
Publicado: (2019)

NAD(+) loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD(+) repletion
por: Diani-Moore, Silvia, et al.
Publicado: (2017)

Enzymology of Ca(2+)-Mobilizing Second Messengers Derived from NAD: From NAD Glycohydrolases to (Dual) NADPH Oxidases
por: Guse, Andreas H.
Publicado: (2023)

Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter
por: Kawamura, Eriko, et al.
Publicado: (2020)

Dieckol Reduces Muscle Atrophy by Modulating Angiotensin Type II Type 1 Receptor and NADPH Oxidase in Spontaneously Hypertensive Rats
por: Oh, Seyeon, et al.
Publicado: (2021)

Rapidly Progressive Heart Failure in a Female Carrier of Becker Muscular Dystrophy with No Skeletal Muscle Symptoms
por: Komoriyama, Hirokazu, et al.
Publicado: (2019)

Oxidative stress in cardiac and skeletal muscle dysfunction associated with diabetes mellitus
por: Tsutsui, Hiroyuki, et al.
Publicado: (2011)

Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species
por: Alili, Lirija, et al.
Publicado: (2014)

NAD(P)H Oxidase Activity in the Small Intestine Is Predominantly Found in Enterocytes, Not Professional Phagocytes
por: Lindquist, Randall L., et al.
Publicado: (2018)

A Versatile Chemoenzymatic Nanoreactor that Mimics NAD(P)H Oxidase for the In Situ Regeneration of Cofactors
por: Rodriguez‐Abetxuko, Andoni, et al.
Publicado: (2022)

Inverse Relationship between Sleep Duration and Cardio-Ankle Vascular Index in Children
por: Morita, Noriteru, et al.
Publicado: (2017)

Nicotinamide Phosphoribosyltransferase‐elevated NAD(+) biosynthesis prevents muscle disuse atrophy by reversing mitochondrial dysfunction
por: Zhang, Yao, et al.
Publicado: (2023)

Ozone affects pollen viability and NAD(P)H oxidase release from Ambrosia artemisiifolia pollen
por: Pasqualini, Stefania, et al.
Publicado: (2011)

Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity
por: Saito, Yuta, et al.
Publicado: (2007)

Cofactor Specificity Engineering of Streptococcus mutans NADH Oxidase 2 for NAD(P)(+) Regeneration in Biocatalytic Oxidations
por: Petschacher, Barbara, et al.
Publicado: (2014)

Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
por: Wang, Peng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qlseqpb4tfl39qrkjkpag3sqmn